Capital Goods Healthcare Sector

Regen BioPharma

Market Cap: US$1.3m

Focuses on the development of regenerative medical applications in the United States.

Dakshidin Corporation

Market Cap: US$1.3m

Through its subsidiaries, operates as a CBD/cannabis-based medical product company.

Appili Therapeutics

Market Cap: CA$1.8m

A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.

Lifeline Biotechnologies

Market Cap: US$1.3m

Operates as a medical technology company in the United States.

Allied

Market Cap: US$1.3m

A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.

INVO Fertility

Market Cap: US$1.3m

A life science portfolio company, develops clinical stage assets to treat patients with fertility, oncology, and autoimmune diseases.

Halberd

Market Cap: US$1.3m

A biotech company, develops treatments for neurodegenerative diseases.

Ocean Biomedical

Market Cap: US$1.3m

A biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States.

Meridian Holdings

Market Cap: US$1.3m

Through its subsidiaries, provides healthcare management and information system solutions in the United States.

Processa Pharmaceuticals

Market Cap: US$1.3m

A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.

Vaxxinity

Market Cap: US$1.3m

A biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.

Non-Invasive Monitoring Systems

Market Cap: US$1.2m

Does not have significant operations.

AdAlta

Market Cap: AU$1.9m

A clinical stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia.

Certive Solutions

Market Cap: CA$1.8m

Provides revenue cycle consultative services and solutions in the United States.

Shortwave Life Sciences

Market Cap: UK£871.8k

Through its subsidiary, Blossom Analysis, provides a data and insights platform for the psychedelic healthcare industry.

Panbela Therapeutics

Market Cap: US$1.2m

A clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs.

Shuttle Pharmaceuticals Holdings

Market Cap: US$1.2m

A clinical stage pharmaceutical company, develops novel therapies to cure cancers.

Adastra Holdings

Market Cap: CA$1.6m

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.

Bespoke Extracts

Market Cap: US$1.1m

Bespoke Extracts, Inc., along with its subsidiary, Bespoke Extracts Colorado, LLC, specializes in the production and sale of pre-rolled marijuana cigarettes in the United States.

Silo Wellness

Market Cap: CA$1.5m

A psychedelics and wellness company, develops psychedelic medicine to reduce trauma.

PreAxia Health Care Payment Systems

Market Cap: US$1.1m

Focuses on the development, distribution, marketing, and sale of health care payment processing services and products.

EHAVE

Market Cap: US$1.1m

A healthcare company, develops medical psychedelics and mental health data platform that integrates with its proprietary and third-party assessment and therapeutic digital applications in Canada.

Captor Capital

Market Cap: CA$1.5m

Engages in the retail sale of cannabis products in the United States.

SPO Global

Market Cap: US$1.1m

Does not have significant operations.

CBD Life Sciences

Market Cap: US$1.1m

Engages in the development and marketing a line of cannabidiol based organic products.

Entheon Biomedical

Market Cap: CA$1.5m

Operates as a biotechnology research and development company.

Modern Mobility Aids

Market Cap: US$1.1m

Operates in the telehealth and telemedicine industry.

New Leaf Ventures

Market Cap: CA$1.5m

Engages in processing, packaging, marketing, and distributing cannabis and related products.

Target Group

Market Cap: US$1.1m

Target Group Inc. cultivates, processes, and distributes curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States.

Access-Power

Market Cap: US$1.1m

A medical marijuana clone company, manufactures and distributes medical marijuana clone products.

Evofem Biosciences

Market Cap: US$1.1m

A biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.

CYduct Diagnostics

Market Cap: US$1.1m

A healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions.

TransCanna Holdings

Market Cap: CA$1.4m

Through its subsidiaries, engages in the manufacturing, transportation, and distribution of cannabis related products in the United States.

Trevena

Market Cap: US$1.0m

A biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders.

Body and Mind

Market Cap: US$1.0m

Body and Mind Inc. cultivates, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, Ohio, Illinois, and New Jersey in the United States.

AXM Pharma

Market Cap: US$1.0m

Manufactures and sells over-the-counter and prescription pharmaceutical products in the People's Republic of China.